Uvantis Therapeutics, Inc. funding

Uvantis Therapeutics, Inc., a biotechnology company based in Columbia, MD (founded 2025), filed a Form D with the SEC on September 23, 2026 and reported $100K raised of a $5M offering.

Amount raised$100K

Offering size$5M

Filed with the SECSeptember 23, 2026

First saleSeptember 10, 2026

IndustryBiotechnology

SecuritiesDebt, Options or warrants

LocationColumbia, MD

Founded2025

Entity typeCorporation

Investors so far1

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Sep 23

Other health care rounds in Maryland

Kaigene, Inc.$55M · Oct 14Biotechnology Seraxis Holdings, Inc.$10M · Sep 24Biotechnology OS Therapies Inc$7.2M · Oct 23Biotechnology Templar Nova, Inc.$7M · Oct 7Biotechnology Accufy Diagnostics, Inc.$2M · Oct 28Biotechnology ColoWatch, Inc. /MD/$975K · Oct 8Other Health Care Drizzle Health, LLC$600K · Nov 10Biotechnology Terrace Systems, Inc.$250K · Sep 16Other Health Care